Chad Messer
Stock Analyst at Lake Street
(0.51)
# 3,986
Out of 4,905 analysts
25
Total ratings
32%
Success rate
-25.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COYA Coya Therapeutics | Initiates: Buy | $16 | $5.81 | +175.39% | 1 | Jul 9, 2025 | |
| BOLT Bolt Biotherapeutics | Initiates: Buy | $80 | $5.53 | +1,346.65% | 1 | May 20, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.99 | +526.57% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $10.58 | +117.39% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.64 | +1,058.54% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $1.17 | +9,643.59% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $13.55 | +269.00% | 1 | Jul 27, 2021 | |
| CYTK Cytokinetics | Maintains: Buy | $33 → $48 | $37.23 | +28.93% | 2 | Jul 19, 2021 | |
| EXEL Exelixis | Maintains: Buy | $33 → $30 | $44.47 | -32.54% | 3 | Jun 28, 2021 | |
| RNA Avidity Biosciences | Initiates: Buy | $50 | $33.76 | +48.10% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $10.86 | +167.03% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.77 | +464.97% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $41.75 | +105.99% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $2.10 | +3,471.43% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $11.21 | +292.51% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $14.08 | +1,079.40% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.86 | +366.32% | 1 | May 5, 2020 |
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $5.81
Upside: +175.39%
Bolt Biotherapeutics
May 20, 2025
Initiates: Buy
Price Target: $80
Current: $5.53
Upside: +1,346.65%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.99
Upside: +526.57%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $10.58
Upside: +117.39%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.64
Upside: +1,058.54%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $1.17
Upside: +9,643.59%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $13.55
Upside: +269.00%
Cytokinetics
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $37.23
Upside: +28.93%
Exelixis
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $44.47
Upside: -32.54%
Avidity Biosciences
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $33.76
Upside: +48.10%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $10.86
Upside: +167.03%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $1.77
Upside: +464.97%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $41.75
Upside: +105.99%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $2.10
Upside: +3,471.43%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $11.21
Upside: +292.51%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $14.08
Upside: +1,079.40%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.86
Upside: +366.32%